News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
57,623 Results
Type
Article (6325)
Company Profile (13)
Press Release (51285)
Multimedia
Podcasts (16)
Webinars (1)
Section
Business (14725)
Career Advice (50)
Deals (2254)
Drug Delivery (11)
Drug Development (12061)
Employer Resources (13)
FDA (1928)
Job Trends (2234)
News (30419)
Policy (5025)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2026 Bio NC Standard (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (1)
Academia (362)
Accelerated approval (1)
Adcomms (3)
Allergies (8)
Alliances (4971)
ALS (2)
Alzheimer's disease (121)
Antibody-drug conjugate (ADC) (8)
Approvals (1952)
Artificial intelligence (12)
Autoimmune disease (3)
Automation (1)
Bankruptcy (28)
Best Places to Work (2085)
BIOSECURE Act (2)
Biosimilars (11)
Biotechnology (8)
Bladder cancer (11)
Brain cancer (2)
Breast cancer (20)
Cancer (210)
Cardiovascular disease (6)
Career advice (47)
CAR-T (22)
Cell therapy (50)
Cervical cancer (5)
Clinical research (8541)
Collaboration (81)
Compensation (11)
Complete response letters (1)
COVID-19 (2040)
CRISPR (3)
C-suite (25)
Cystic fibrosis (9)
Data (237)
Depression (1)
Diabetes (9)
Diagnostics (371)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (11)
Drug pricing (6)
Drug shortages (2)
Duchenne muscular dystrophy (4)
Earnings (4759)
Editorial (11)
Employer branding (1)
Employer resources (12)
Events (6761)
Executive appointments (48)
FDA (2113)
Featured Employer (3)
Frontotemporal dementia (1)
Funding (64)
Gene editing (11)
Generative AI (2)
Gene therapy (30)
GLP-1 (73)
Government (1824)
Grass and pollen (2)
Guidances (5)
Healthcare (1721)
IgA nephropathy (1)
Immunology and inflammation (15)
Indications (2)
Infectious disease (2146)
Inflammatory bowel disease (18)
Inflation Reduction Act (1)
Influenza (45)
Intellectual property (7)
Interviews (4)
IPO (993)
IRA (5)
Job creations (288)
Job search strategy (47)
Labor market (1)
Layoffs (70)
Legal (480)
Liver cancer (2)
Lung cancer (16)
Lymphoma (20)
Management (7)
Manufacturing (47)
MASH (1)
Medical device (363)
Medtech (363)
Mergers & acquisitions (1293)
Metabolic disorders (32)
Multiple sclerosis (16)
Neurodegenerative disease (5)
Neuropsychiatric disorders (1)
Neuroscience (156)
NextGen: Class of 2025 (334)
Non-profit (331)
Northern California (138)
Now hiring (5)
Obesity (17)
Opinion (29)
Ovarian cancer (17)
Pain (3)
Pancreatic cancer (5)
Parkinson's disease (7)
Partnered (2)
Patents (26)
Patient recruitment (1)
Peanut (6)
People (4282)
Pharmaceutical (5)
Phase I (3042)
Phase II (3546)
Phase III (3222)
Pipeline (121)
Policy (42)
Postmarket research (385)
Preclinical (1183)
Press Release (19)
Prostate cancer (7)
Psychedelics (4)
Radiopharmaceuticals (11)
Rare diseases (40)
Real estate (484)
Recruiting (5)
Regulatory (3247)
Reports (11)
Research institute (380)
Resumes & cover letters (2)
RNA editing (2)
RSV (49)
Schizophrenia (1)
Series A (5)
Series B (4)
Service/supplier (1)
Sickle cell disease (5)
Southern California (132)
Spinal muscular atrophy (2)
Sponsored (4)
Startups (269)
Supply chain (11)
Tariffs (8)
The Weekly (15)
United States (1848)
Vaccines (793)
Venture capitalists (4)
Weight loss (17)
Date
Today (10)
Last 7 days (44)
Last 30 days (194)
Last 365 days (2932)
2025 (840)
2024 (3143)
2023 (3752)
2022 (6872)
2021 (7810)
2020 (6266)
2019 (2774)
2018 (2123)
2017 (2121)
2016 (2107)
2015 (2561)
2014 (1987)
2013 (1618)
2012 (1811)
2011 (1950)
2010 (1810)
Location
Africa (162)
Alabama (20)
Alaska (1)
Arizona (3)
Asia (3939)
Australia (623)
California (330)
Canada (145)
China (35)
Colorado (14)
Connecticut (21)
Delaware (12)
Europe (9332)
Florida (44)
Georgia (40)
Idaho (1)
Illinois (17)
India (5)
Indiana (24)
Iowa (1)
Japan (20)
Kansas (8)
Kentucky (2)
Maine (1)
Maryland (281)
Massachusetts (257)
Michigan (8)
Minnesota (7)
Missouri (4)
Montana (8)
Nebraska (2)
Nevada (1)
New Hampshire (1)
New Jersey (321)
New Mexico (3)
New York (160)
North Carolina (51)
North Dakota (6)
Northern California (138)
Ohio (9)
Pennsylvania (136)
Puerto Rico (1)
Rhode Island (6)
South America (97)
South Carolina (1)
Southern California (132)
Tennessee (3)
Texas (33)
Utah (5)
Virginia (11)
Washington D.C. (3)
Washington State (40)
Wisconsin (1)
57,623 Results for "eurocine vaccines".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Government
Kennedy Changes Tune on MMR Vaccine as Second Child Dies of Measles
Kennedy, a long-time opponent of vaccines, stated that the MMR vaccine is “the most effective way” to combat the measles outbreak, which has already claimed the lives of two children in the U.S.
April 7, 2025
·
2 min read
·
Tristan Manalac
Outstanding results for Eurocine Vaccines´ mRNA based HSV-2 candidate
As communicated earlier, Eurocine Vaccines is conducting preclinical trials to evaluate the mRNA and protein technology platforms for its therapeutic Herpes simplex virus type 2, HSV-2, vaccine candidates.
December 20, 2022
·
2 min read
Business
Eurocine Vaccines expands its portfolio with a therapeutic HSV-2 vaccine candidate
Eurocine Vaccines AB (“Eurocine Vaccines”) hereby announces that the company has entered into a research and collaboration agreement with Redbiotec AG (“Redbiotec”).
June 14, 2022
·
3 min read
Policy
RFK Jr. Eyes Changes to Vaccines Injury Surveillance System to Deduce ‘Culprit’
Kennedy is planning modifications to the Vaccines Adverse Event Reporting System to identify whether vaccines contribute to an unstated problem. The reporting system is at the heart of the departure of CBER head Peter Marks.
April 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
VIVALDI BIOSCIENCES’ UNIVERSAL INFLUENZA VACCINE SHOWS POTENTIAL TO BLOCK VIRUS TRANSMSSION AND DISEASE SPREAD
Study Results to be Presented at World Vaccine Congress
April 17, 2025
·
1 min read
Vaccines
FDA Issues Back-to-Back Vaccine Approvals as RFK Jr. Takes HHS Seat
The approvals come as Robert F. Kennedy Jr.—who has been critical of vaccines—takes leadership of the Department of Health and Human Services.
February 17, 2025
·
2 min read
·
Tristan Manalac
Vaccines
HHS Pulls Funding for GeoVax’s Next-Gen COVID-19 Vaccine
GeoVax was using its HHS contract to develop its next-generation multi-antigen COVID-19 vaccine, which is in Phase IIb development.
April 17, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Doctors Rally Behind Vaccines as Doubts, Misinformation Mount
A group of medical experts expressed concern about growing “disinformation” and “misinformation,” calling for adherence to recommended vaccine schedules.
March 20, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Sales of Merck’s 4-Way Measles Vaccine Take Hit as US Dips Into Stockpile
Proquad is rarely a newsmaker from Merck’s earnings, but this time around, the U.S. has had a series of measles outbreaks. Sales of the vaccine were $539 million for the quarter, a 5% decline from the same period in 2024.
April 24, 2025
·
2 min read
·
Annalee Armstrong
Vaccines
FDA Pauses Study of BioNTech’s Malaria Shot as Problems for Vaccine Space Mount
The vaccine space has been battered by strong headwinds in recent weeks, including high-level disruptions to FDA and CDC advisory committee meetings.
March 5, 2025
·
2 min read
·
Tristan Manalac
1 of 5,763
Next
